Animal Pharmaceuticals Market by Product Type and Animal Type- Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 160 Category: Pharmaceuticals Report Code : HC063949
Animal Pharmaceuticals Market by Product Type (Anti-Inflammatories, Vaccine, Veterinary Drugs, Bronchodilators) Animal Type(Production Animals, Companion Animals) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Animal pharmaceuticals are utilized to treat or avert maladies and diseases. Animal pharmaceuticals are accessible in an assortment of structures, which enables veterinarian to oversee required prescriptions, for example, fluids, pills, infusions, and powders. Creature pharmaceuticals are managed by the Food and Drug Administration (FDA) Center for veterinary prescriptions.
Drivers and Restraints
Animal pharmaceuticals are utilized to treat or avert maladies and contaminations. Creature pharmaceuticals are accessible in an assortment of structures, which enables veterinarian to oversee required prescriptions, for example, fluids, pills, infusions, and powders. Animal pharmaceuticals are controlled by the Food and Drug Administration (FDA) Center for veterinary medicines. However, stringent standards and guidelines in creature testing and limitations forced by administrative experts may hamper development of worldwide market over the figure time frame.
Regional Insights
North America is relied upon to command worldwide Animal pharmaceuticals showcase, inferable from variables, for example, elevated expectation of living and expanding mindfulness in regards to sicknesses related with domesticated animals and buddy creatures.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Vetoquinol S.A.
- Merck & Co. Inc.
- Sanofi and Bayer AG.
- Zoetis Inc.
- Eli Lilly and Company
- Phirbo Animal Health
- Boehringer Ingelheim GmbH
- Perrigo Company plc
- Virbac SA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Animal Pharmaceuticals Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Anti-Inflammatories
o Vaccine
o Veterinary Drugs
o Bronchodilators
· Animal Pharmaceuticals Market, By Animal Type, Estimates and Forecast, 2017-2027 ($Million)
o Production Animals
o Companion Animals
· Animal Pharmaceuticals Market, By Key Players
o Vetoquinol S.A.
o Merck & Co. Inc.
o Sanofi and Bayer AG.
o Zoetis Inc.
o Eli Lilly and Company
o Phirbo Animal Health
o Boehringer Ingelheim GmbH
o Perrigo Company plc
o Virbac SA
· Animal Pharmaceuticals Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Animal Pharmaceuticals Market, By Country
o U.S. Animal Pharmaceuticals Market
o Canada Animal Pharmaceuticals Market
o Mexico Animal Pharmaceuticals Market
o Europe
§ Europe Animal Pharmaceuticals Market, By Country
o Germany Animal Pharmaceuticals Market
o UK Animal Pharmaceuticals Market
o France Animal Pharmaceuticals Market
o Russia Animal Pharmaceuticals Market
o Italy Animal Pharmaceuticals Market
o Rest of Europe Animal Pharmaceuticals Market
o Asia-Pacific
§ Asia-Pacific Animal Pharmaceuticals Market, By Country
o China Animal Pharmaceuticals Market
o Japan Animal Pharmaceuticals Market
o South Korea Animal Pharmaceuticals Market
o India Animal Pharmaceuticals Market
o Southeast Asia Animal Pharmaceuticals Market
o Rest of Asia-Pacific Animal Pharmaceuticals Market
o South America
§ South America Animal Pharmaceuticals Market
o Brazil Animal Pharmaceuticals Market
o Argentina Animal Pharmaceuticals Market
o Columbia Animal Pharmaceuticals Market
o Rest of South America Animal Pharmaceuticals Market
o Middle East and Africa
§ Middle East and Africa Animal Pharmaceuticals Market
o Saudi Arabia Animal Pharmaceuticals Market
o UAE Animal Pharmaceuticals Market
o Egypt Animal Pharmaceuticals Market
o Nigeria Animal Pharmaceuticals Market
o South Africa Animal Pharmaceuticals Market
o Rest of MEA Animal Pharmaceuticals Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Animal Pharmaceuticals Market, By Product Type
5.1. Introduction
5.2. Global Animal Pharmaceuticals Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Animal Pharmaceuticals Revenue and Revenue Share by Product Type (2017-2027)
5.3. Anti-Inflammatories
5.3.1. Global Anti-Inflammatories Revenue and Growth Rate (2017-2027)
5.4. Vaccine
5.4.1. Global Vaccine Revenue and Growth Rate (2017-2027)
5.5. Veterinary Drugs
5.5.1. Global Veterinary Drugs Revenue and Growth Rate (2017-2027)
5.6. Bronchodilators
5.6.1. Global Bronchodilators Revenue and Growth Rate (2017-2027)
6. Animal Pharmaceuticals Market, By Animal Type
6.1. Introduction
6.2. Global Animal Pharmaceuticals Revenue and Market Share by Animal Type (2017-2027)
6.2.1. Global Animal Pharmaceuticals Revenue and Revenue Share by Animal Type (2017-2027)
6.3. Production Animals
6.3.1. Global Production Animals Revenue and Growth Rate (2017-2027)
6.4. Companion Animals
6.4.1. Global Companion Animals Revenue and Growth Rate (2017-2027)
7. Animal Pharmaceuticals Market, By Region
7.1. Introduction
7.2. Global Animal Pharmaceuticals Revenue and Market Share by Regions
7.2.1. Global Animal Pharmaceuticals Revenue by Regions (2017-2027)
7.3. North America Animal Pharmaceuticals by Countries
7.3.1. North America Animal Pharmaceuticals Revenue and Growth Rate (2017-2027)
7.3.2. North America Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Animal Pharmaceuticals by Countries
7.4.1. Europe Animal Pharmaceuticals Revenue and Growth Rate (2017-2027)
7.4.2. Europe Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Animal Pharmaceuticals by Countries
7.5.1. Asia-Pacific Animal Pharmaceuticals Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Animal Pharmaceuticals by Countries
7.6.1. South America Animal Pharmaceuticals Revenue and Growth Rate (2017-2027)
7.6.2. South America Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Animal Pharmaceuticals by Countries
7.7.1. Middle East and Africa Animal Pharmaceuticals Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Vetoquinol S.A.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Merck & Co. Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Sanofi and Bayer AG.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Zoetis Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Eli Lilly and Company
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Phirbo Animal Health
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Boehringer Ingelheim GmbH
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Perrigo Company plc
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Virbac SA
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
9. Animal Pharmaceuticals Market Forecast (2017-2027)
9.1. Global Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Animal Pharmaceuticals Market Forecast by Regions (2017-2027)
9.2.1. North America Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.1.1. United States Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.1.2. Canada Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.1.3. Mexico Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2. Europe Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2.1. Germany Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2.2. France Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2.3. UK Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2.4. Russia Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2.5. Italy Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3. Asia-Pacific Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3.1. China Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3.2. Japan Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3.3. Korea Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3.4. India Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.4. South America Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.4.1. Brazil Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.4.2. Argentina Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.4.3. Columbia Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.4.4. Rest of South America Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5. Middle East and Africa Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.3. Egypt Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.4. Nigeria Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.5. South Africa Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.6. Turkey Animal Pharmaceuticals Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Animal Pharmaceuticals Market Forecast (2017-2027)
9.3. Animal Pharmaceuticals Market Forecast by Product Type (2017-2027)
9.3.1. Animal Pharmaceuticals Forecast by Product Type (2017-2027)
9.3.2. Animal Pharmaceuticals Market Share Forecast by Product Type (2017-2027)
9.4. Animal Pharmaceuticals Market Forecast by Animal Type (2017-2027)
9.4.1. Animal Pharmaceuticals Forecast by Animal Type (2017-2027)
9.4.2. Animal Pharmaceuticals Market Share Forecast by Animal Type (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Animal Pharmaceuticals Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Animal Pharmaceuticals Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Anti-Inflammatories Revenue and Growth Rate (2017-2018)
Figure Global Vaccine Revenue and Growth Rate (2017-2018)
Figure Global Veterinary Drugs Revenue and Growth Rate (2017-2018)
Figure Global Bronchodilators Revenue and Growth Rate (2017-2018)
Table Global Animal Pharmaceuticals Revenue and Revenue Share by Animal Type (2017-2018)
Figure Global Production Animals Revenue and Growth Rate (2017-2018)
Figure Global Companion Animals Revenue and Growth Rate (2017-2018)
Table Global Animal Pharmaceuticals Revenue by Regions (2017-2018)
Figure North America Animal Pharmaceuticals Growth Rate (2017-2018)
Figure North America Animal Pharmaceuticals Revenue and Growth Rate (2017-2018)
Figure North America Animal Pharmaceuticals by Countries (2017-2018)
Figure North America Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2018)
Figure United States Animal Pharmaceuticals Growth Rate (2017-2018)
Figure United States Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Canada Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Mexico Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Europe Animal Pharmaceuticals Revenue and Growth Rate (2017-2018)
Figure Europe Animal Pharmaceuticals by Countries (2017-2018)
Figure Europe Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2018)
Figure Germany Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Germany Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Animal Pharmaceuticals Growth Rate (2017-2018)
Figure France Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Animal Pharmaceuticals Growth Rate (2017-2018)
Figure UK Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Russia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Italy Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Rest of Europe Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Asia-Pacific Animal Pharmaceuticals Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Animal Pharmaceuticals by Countries (2017-2018)
Figure Asia-Pacific Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2018)
Figure China Animal Pharmaceuticals Growth Rate (2017-2018)
Figure China Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Japan Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Korea Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Animal Pharmaceuticals Growth Rate (2017-2018)
Figure India Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Southeast Asia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Animal Pharmaceuticals Growth Rate (2017-2018)
Figure South America Animal Pharmaceuticals Revenue and Growth Rate (2017-2018)
Figure South America Animal Pharmaceuticals by Countries (2017-2018)
Figure South America Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Brazil Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Argentina Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Columbia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Rest of South America Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Middle East and Africa Animal Pharmaceuticals Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Animal Pharmaceuticals by Countries (2017-2018)
Figure Middle East and Africa Animal Pharmaceuticals Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Saudi Arabia Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Animal Pharmaceuticals Growth Rate (2017-2018)
Figure United Arab Emirates Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Egypt Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Nigeria Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Animal Pharmaceuticals Growth Rate (2017-2018)
Figure South Africa Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Turkey Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Animal Pharmaceuticals Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2017-2018)
Table Vetoquinol S.A. Animal Pharmaceuticals Financial Overview
Table Merck & Co. Inc. Animal Pharmaceuticals Financial Overview
Table Sanofi and Bayer AG. Animal Pharmaceuticals Financial Overview
Table Zoetis Inc. Animal Pharmaceuticals Financial Overview
Table Eli Lilly and Company Animal Pharmaceuticals Financial Overview
Table Phirbo Animal Health Animal Pharmaceuticals Financial Overview
Table Boehringer Ingelheim GmbH Animal Pharmaceuticals Financial Overview
Table Perrigo Company plc Animal Pharmaceuticals Financial Overview
Table Virbac SA Animal Pharmaceuticals Financial Overview
Figure Global Animal Pharmaceuticals Revenue (Millions USD) and Growth Rate (2018-2025)
Table Animal Pharmaceuticals Market Forecast by Regions (2018-2025)
Figure North America Animal Pharmaceuticals Market Forecast (2018-2025)
Figure United States Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Canada Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Mexico Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Europe Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Germany Animal Pharmaceuticals Market Forecast (2018-2025)
Figure France Animal Pharmaceuticals Market Forecast (2018-2025)
Figure UK Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Russia Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Italy Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Rest of Europe Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Asia-Pacific Animal Pharmaceuticals Market Forecast (2018-2025)
Figure China Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Japan Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Korea Animal Pharmaceuticals Market Forecast (2018-2025)
Figure India Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Southeast Asia Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Animal Pharmaceuticals Market Forecast (2018-2025)
Figure South America Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Brazil Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Argentina Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Columbia Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Rest of South America Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Middle East and Africa Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Saudi Arabia Animal Pharmaceuticals Market Forecast (2018-2025)
Figure United Arab Emirates Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Egypt Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Nigeria Animal Pharmaceuticals Market Forecast (2018-2025)
Figure South Africa Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Turkey Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Animal Pharmaceuticals Market Forecast (2018-2025)
Figure Global Animal Pharmaceuticals Forecast by Product Type (2018-2025)
Figure Global Animal Pharmaceuticals Market Share Forecast by Product Type (2018-2025)
Figure Global Animal Pharmaceuticals Forecast by Product Type (2018-2025)
Figure Global Animal Pharmaceuticals Forecast by Animal Type (2018-2025)
Figure Global Animal Pharmaceuticals Market Share Forecast by Animal Type (2018-2025)
Figure Global Animal Pharmaceuticals Forecast by Animal Type (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|